ENTPD2 transforms extracellular ATP into 5′‐AMP and further suppresses the differentiation of myeloid‐derived suppressor cells (MDSCs), thus facilitating the maintenance of MDSCs and the development of tumor immunosuppressive microenvironment. This evidence concerns the gene ENTPD2 and neoplasm.